Search results
Decoding Amgen Inc (AMGN): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 3 weeks agoAmgen Inc's robust product portfolio and strategic acquisitions position it as a biotech leader. Financial performance shows resilience amid...
Amgen Inc. (NASDAQ:AMGN) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 weeks agoAmgen Inc. (NASDAQ:AMGN) Q1 2024 Earnings Call Transcript May 2, 2024 Amgen Inc. beats earnings...
Q4 2023 Amgen Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 4 months agoParticipants David M. Reese; Executive VP & CTO; Amgen Inc. James E. Bradner; Executive VP of Research and Development & Chief Scientific Officer; Amgen Inc. Justin Claeys Murdo Gordon; Executive ...
U.S. Supreme Court mulls Amgen bid to revive cholesterol drug patents
Reuters via Yahoo News· 1 year agoWASHINGTON (Reuters) -Amgen Inc sought to convince the U.S. Supreme Court on Monday to revive...
Amgen Inc (AMGN) Q1 2024 Earnings Call Transcript Highlights: Strong Growth and Strategic Advances
GuruFocus.com via Yahoo Finance· 3 weeks agoTotal Revenue: $7.4 billion, up 22% year-over-year. Product Sales: Excluding Horizon products, increased 6% year-over-year. Operating Margin: Q1 operating margin was 43%. Free Cash Flow: $0.5 ...
The Biggest Biotechnology Company in Europe
Insider Monkey via Yahoo Finance· 10 hours agoWe’ve recently covered a list of 20 Biggest Publicly-Traded Biotech Companies based on market caps that you can visit here. Biotechnology and Industry...
Amgen Inc. -- Moody's assigns Baa1 rating to Amgen's notes; stable outlook
Moody's via Yahoo Finance· 2 years agoRating Action: Moody's assigns Baa1 rating to Amgen's notes; stable outlookGlobal Credit Research - 15 Aug 2022New York, August 15, 2022 -- Moody's Investors Service ("Moody's") assigned a Baa1 ...
Two Down With Sanofi Bowing Out From Horizon Buyout Talks, Amgen Agrees To Buy For $116.5/Share
Benzinga via Yahoo Finance· 1 year agoAmgen Inc (NASDAQ: AMGN) has agreed to buy Horizon Therapeutics plc (NASDAQ: HZNP), implying an...
Amgen Soars as CEO Touts Experimental Obesity Drug Progress
Bloomberg via Yahoo Finance· 3 weeks ago(Bloomberg) -- Amgen Inc.’s shares soared after its chief executive officer said he was “very...
Should You Consider Selling Amgen (AMGN)?
Insider Monkey via Yahoo Finance· 8 months agoClearBridge Investments, an investment management company, released its “ClearBridge Large Cap Value Strategy” second quarter 2023 investor letter. A...
